{
    "body_text": [
        {
            "endOffset": 28073,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In this case definition and associated guideline, we propose a systemic tool for evaluating the adverse event of SGA after maternal immunisation.",
            "startOffset": 27928,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 62698,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "The method, frequency and duration of monitoring for SGA;",
            "startOffset": 62641,
            "title": "Data presentation"
        },
        {
            "endOffset": 41674,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0040",
            "sentence": "Assessment through imaging (ultrasound) at different gestational ages in pregnancy has been included to meet case definition for levels of certainty 1A to 3A, as ultrasound represents the most accurate method for assessment of gestational age.",
            "startOffset": 41431,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 62261,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 62151,
            "title": "Data presentation"
        },
        {
            "endOffset": 24144,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Limited data exist on the effect of vaccinations in high-risk pregnancies.",
            "startOffset": 24070,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43292,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "Instead, where feasible, information on the timing of vaccine administration during pregnancy should be collected, assessed and reported as described in the data collection guidelines and the ascertainment of whether or not the infant is SGA and the associated Brighton level should be determined by personnel blinded to the vaccine status of the mother.",
            "startOffset": 42938,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 33230,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The majority of the available reference populations were from North America (n = 12) with some from Europe (n = 6) and Asia (n = 5), and few from Africa (n = 2) and South America (n = 1) [66].",
            "startOffset": 33038,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19442,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Small for gestational age (SGA) fetuses or newborns are those smaller in size than normal for their gestational age, most commonly defined as a weight below the 10th percentile for the gestational age.",
            "startOffset": 19241,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 38836,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0025",
            "sentence": "Within the definition context, however, the three diagnostic levels must not be misunderstood as reflecting different grades of clinical severity.",
            "startOffset": 38690,
            "title": "The term small for gestational age"
        },
        {
            "endOffset": 37802,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "This review resulted in a summary of 26 articles, including information on the diagnostic criteria or case definition put forth and the vaccine used (summarized in Table 2).",
            "startOffset": 37629,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for SGA as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27030,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "IUGR refers to a fetus that is unable to achieve its genetically determined potential size.",
            "startOffset": 26939,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 52233,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0135",
            "sentence": "Immunisation history (i.e. previous immunisations and any adverse event following immunisation (AEFI)), in particular occurrence of SGA after a previous immunisation.",
            "startOffset": 52067,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 50346,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0120",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 50240,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 52408,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Date and time of immunisation(s).",
            "startOffset": 52375,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 28933,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The remaining published studies were observational in design and used different SGA definitions and reference standards (Table 2) [32,33].",
            "startOffset": 28795,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 44092,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0055",
            "sentence": "Additionally, IUGR implies the presence of a pathological condition that occurs in utero and results in diminished fetal growth.",
            "startOffset": 43964,
            "title": "Differentiation from other (similar/associated) disorders"
        },
        {
            "endOffset": 49220,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0115",
            "sentence": "The guidelines are not intended to guide the primary reporting of SGA to a surveillance system or study monitor.",
            "startOffset": 49108,
            "title": "Data collection"
        },
        {
            "endOffset": 37628,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "All abstracts were screened for possible reports of small for gestational age following immunisation.",
            "startOffset": 37527,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for SGA as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30743,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Other less utilized SGA definitions in the literature include having a birth weight 2 standard deviations below the standard for gestational age or a birth weight for gestational age below the 5th or 3rd centile [60,61].",
            "startOffset": 30523,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 62874,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation;",
            "startOffset": 62699,
            "title": "Data presentation"
        },
        {
            "endOffset": 33388,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The majority of the charts used LMP dates to define gestational age reported to the nearest week, while some used ultrasound or best obstetric estimate [66].",
            "startOffset": 33231,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 62147,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g. manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population based data, etc.).",
            "startOffset": 61920,
            "title": "Data presentation"
        },
        {
            "endOffset": 43639,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "In order to avoid selecting against such cases, the Brighton Collaboration case definition avoids setting arbitrary time frames.",
            "startOffset": 43511,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 44547,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0060",
            "sentence": "As mentioned in the overview paper, the case definition is accompanied by guidelines which are structured according to the steps of conducting a clinical trial, i.e. data collection, analysis and presentation.",
            "startOffset": 44338,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 23109,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Placental malaria is a major cause of fetal growth restriction.",
            "startOffset": 23046,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 55077,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Objective clinical evidence supporting classification of the event as \u201cserious\u201d.11",
            "startOffset": 54584,
            "title": "The adverse event"
        },
        {
            "endOffset": 39394,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0030",
            "sentence": "Our definition and Brighton level classification scheme draw upon their work.",
            "startOffset": 39317,
            "title": "Related terms - small for gestational age"
        },
        {
            "endOffset": 34604,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is likely though that the use of customized charts is associated with improved identification of SGA fetuses of mothers who smoke, have a high body mass index or other pathologies [85].",
            "startOffset": 34416,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42937,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "Therefore, to avoid selection bias, a restrictive time interval from vaccination to birth should not be an integral part of such a definition.",
            "startOffset": 42795,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 49107,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0115",
            "sentence": "These guidelines represent a desirable standard for the collection of data on availability following immunisation to allow for comparability of data, and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 48860,
            "title": "Data collection"
        },
        {
            "endOffset": 34286,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The use of Hadlock\u2019s proportionality formula to construct these customized charts results in a substantially higher proportion of preterm infants being identified as SGA.",
            "startOffset": 34116,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30522,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Some infants classified as SGA will include newborns who are constitutionally small and are in the lower tail of the growth curve distribution, while others will include newborns who are growth restricted in utero due to one or more growth-inhibiting factors such as malnutrition, placental insufficiency, pregnancy complications as preeclampsia, and/or infection [2,60].",
            "startOffset": 30151,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 38086,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Most publications defined SGA as the lowest 10th percentile of the gestational age-specific birth weight within the cohort of live births, not stratified or stratified by gender [20,22,34\u201347].",
            "startOffset": 37894,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for SGA as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21662,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It can indirectly, through macrophages, upregulate the anti-angiogenic soluble vascular endothelial growth factor receptor-1 (SFlt-1).",
            "startOffset": 21528,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 56818,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0155",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 56711,
            "title": "Data analysis"
        },
        {
            "endOffset": 42385,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "It is expected that the birth weight and gestational age would have been obtained by a method consistent with the Brighton Collaboration standards.",
            "startOffset": 42238,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 35680,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A positive effect of immunisation in pregnancy might be that the infant is less likely to be SGA.",
            "startOffset": 35583,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 50983,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 50877,
            "title": "Demographics"
        },
        {
            "endOffset": 51226,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "Full name should be used if privacy rules permit to avoid a misclassification.",
            "startOffset": 51148,
            "title": "Demographics"
        },
        {
            "endOffset": 21446,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Dysfunction of the maternal innate immune response may predispose to placentally mediated diseases such as pre-eclampsia (PET), fetal growth restriction (FGR), placental abruption, and intrauterine fetal death.",
            "startOffset": 21236,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26103,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This \u201cdecompensation phase\u201d can be recognised by abnormal venous Doppler waveforms (absent or negative \u2018a\u2019 wave) and it is associated with fetal acidaemia.",
            "startOffset": 25948,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21057,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The third pro-inflammatory phase is similar to the first phase, and it is a preparatory stage for delivery [3].",
            "startOffset": 20946,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51452,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0135",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 51346,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 30880,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Using a more restrictive than a liberal definition captures more severe cases of SGA rather than infants who are constitutionally small.",
            "startOffset": 30744,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25801,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This \u201ccompensatory phase\u201d can be recognised by observing Doppler changes (reduced resistance) in the middle cerebral artery (MCA), decreased amniotic fluid, and/or bright echogenic bowel.",
            "startOffset": 25614,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40107,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0035",
            "sentence": "It needs to be re-emphasised that the grading of definition levels is entirely about diagnostic certainty, not clinical severity of an event.",
            "startOffset": 39966,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 49830,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0115",
            "sentence": "Guideline numbers below have been developed to address data elements for the collection of adverse event information as specified in general drug safety guidelines by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use [92], and the form for reporting of drug adverse events by the Council for International Organizations of Medical Sciences [93].",
            "startOffset": 49413,
            "title": "Data collection"
        },
        {
            "endOffset": 31006,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Essential to the SGA definition is accurate dating of gestational age [62,63] and accurate assessment of birth weight [27,61].",
            "startOffset": 30880,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 20858,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The second anti-inflammatory phase, occurring during mid-pregnancy, is a unique period of fetal growth and development.",
            "startOffset": 20739,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40290,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0035",
            "sentence": "Thus, a clinically very severe event may appropriately be classified as Level Two or Three rather than Level One if it could reasonably be of non-small for gestational age aetiology.",
            "startOffset": 40108,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 31541,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The accuracy of newborn physical examination (\u00b113 days for Dubowitz) is influenced by the complexity of the score used and the examiner\u2019s expertise level [64].",
            "startOffset": 31382,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 24512,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Trotta and colleagues evaluated the safety of A/H1N1 pandemic vaccination of 6246 pregnant women [20].",
            "startOffset": 24410,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51257,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "Date of birth, age, and sex.",
            "startOffset": 51229,
            "title": "Demographics"
        },
        {
            "endOffset": 62456,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 62391,
            "title": "Data presentation"
        },
        {
            "endOffset": 29880,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "No published studies, however, provided details of how the birth weight was measured (e.g. the type of scales used) or specified the age (in days) at which the measurements were taken.",
            "startOffset": 29696,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 56435,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0155",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on SGA to allow for comparability of data, and are recommended as an addition to data analysed for the specific study question and setting.",
            "startOffset": 56219,
            "title": "Data analysis"
        },
        {
            "endOffset": 37104,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the working and reference group as well as results of the web-based survey completed by the reference group with subsequent discussions in the working group can be viewed at: http://www.brightoncollaboration.org/internet/en/index/working_groups.html.",
            "startOffset": 36835,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for SGA as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32193,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Reference charts are descriptive, include both low-risk and high-risk pregnancies, and specify growth in a particular place and time [68,69].",
            "startOffset": 32052,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 20409,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Current evidence suggests that the placenta creates a micro-environment that controls immune cell differentiation at the implantation site and trophoblastic cell-induced differentiation of the immune cells into a phenotype beneficial for the trophoblast [5].",
            "startOffset": 20151,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54580,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Outcome9 at last observation.",
            "startOffset": 54551,
            "title": "The adverse event"
        },
        {
            "endOffset": 52598,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose (e.g. 0.25 mL, 0.5 mL, etc.) and number of dose if part of a series of immunisations against the same disease).",
            "startOffset": 52412,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 38424,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0025",
            "sentence": "Small for gestational age (SGA) is commonly used as a surrogate marker of low fetal growth trajectories, and is indeed associated with increased perinatal mortality and morbidity.",
            "startOffset": 38245,
            "title": "The term small for gestational age"
        },
        {
            "endOffset": 32612,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This standard, based on a low-medium risk group of pregnant women, is for infants born at 33\u201342 weeks\u2019 gestation as too few women gave birth to infants prior to 33 weeks [71].",
            "startOffset": 32437,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 56567,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0155",
            "sentence": "Reported events should be classified in one of the following five categories including the three levels of diagnostic certainty.",
            "startOffset": 56439,
            "title": "Data analysis"
        },
        {
            "endOffset": 39178,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0030",
            "sentence": "Principle consideration was given to both the assessment of gestational age and assessment of size/weight as both these formed the foundation for our definition.",
            "startOffset": 39017,
            "title": "Related terms - small for gestational age"
        },
        {
            "endOffset": 34988,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Preterm infants are known to be smaller than in utero infants given the underlying pathological determinants, such as preeclampsia and other hypertensive disorders that impair fetal growth and increase the risk of preterm birth [86\u201388].",
            "startOffset": 34752,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 55235,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Exposures other than the immunisation 24 h before and after immunisation (e.g. food, environmental) considered potentially relevant to the reported event.",
            "startOffset": 55081,
            "title": "The adverse event"
        },
        {
            "endOffset": 61646,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Terms to describe SGA such as \u201clow-grade\u201d, \u201cmild\u201d, \u201cmoderate\u201d, \u201chigh\u201d, \u201csevere\u201d or \u201csignificant\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 61450,
            "title": "Data presentation"
        },
        {
            "endOffset": 27349,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Neonates born with severe SGA (or with severe short stature) are defined as having a length less than 2.5 standard deviation below the mean [26].",
            "startOffset": 27204,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21775,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In addition, SFlt-1 can combine with soluble endoglin (sEnd) to induce PET, FGR, and coagulation defects [7\u201310].",
            "startOffset": 21663,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35398,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Although there is a broadly accepted definition of SGA, the aforementioned complexities involved in its evaluation, including the accurate measurement of birth weight, the determination of gestational age, and the reference chart used to analyze these data, indicate that a standardized definition of SGA is desirable.",
            "startOffset": 35080,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 38689,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0025",
            "sentence": "In order to define perinatal outcomes and identify safety issues during maternal immunisation trials, this Brighton Collaboration case definition of small for gestational age focuses on recommendations to simultaneously define both birthweight and gestational age.",
            "startOffset": 38425,
            "title": "The term small for gestational age"
        },
        {
            "endOffset": 51997,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0135",
            "sentence": "Any medication history (other than treatment for the event described) prior to, during, and after immunisation including prescription and non-prescription medication, as well as medication or treatment with long half-life or long term effect.",
            "startOffset": 51755,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 19808,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Successful pregnancy, including optimal growth of the fetus, relies on a careful balance between immune tolerance and suppression.",
            "startOffset": 19678,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39316,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0030",
            "sentence": "Accordingly, we worked closely with the GAIA workgroups assigned to assessment of prematurity [62,63] and also for low birth weight [27].",
            "startOffset": 39179,
            "title": "Related terms - small for gestational age"
        },
        {
            "endOffset": 50634,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0120",
            "sentence": "Name and contact information of person reporting5 and/or diagnosing the SGA as specified by country-specific data protection law.",
            "startOffset": 50367,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 33582,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Customizing fetal size for maternal height, weight and ethnicity, has been shown to improve the identification of babies who are small because of FGR, rather than constitutional reasons [72\u201377].",
            "startOffset": 33388,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26509,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Despite the presence of many pathophysiological events that may lead to intrauterine growth restriction, SGA is not universally associated with growth restriction.",
            "startOffset": 26346,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31381,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Gestational age assessment based on last menstrual period (LMP) date has lower accuracy (\u00b114 days) given different cycle duration in women, ovulation/conception timing, and recall error [65].",
            "startOffset": 31190,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33918,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Furthermore, it is important to point out a major criticism to the customized fetal growth charts.",
            "startOffset": 33820,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25947,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This phase is followed by a phase of myocardial dysfunction and haemodynamic decompensation.",
            "startOffset": 25855,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39656,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0030",
            "sentence": "In addition, SGA, which assesses the size of the infant in relation to its maturity after birth, is closely related to inter-uterine growth retardation which assesses the growth of the fetus up until the time of birth and when present predicts for an SGA infant.",
            "startOffset": 39394,
            "title": "Related terms - small for gestational age"
        },
        {
            "endOffset": 39856,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0030",
            "sentence": "These two entities, while closely related, use very different assessment tools, so our definition presented here acknowledges the work of the GAIA IUGR group [12] but did not draw upon their methods.",
            "startOffset": 39657,
            "title": "Related terms - small for gestational age"
        },
        {
            "endOffset": 37893,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Multiple general medical, paediatric and infectious disease text books were also searched.",
            "startOffset": 37803,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for SGA as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23046,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Many clinicians think that TORCH screens should be performed on every SGA newborn infant [15\u201317].",
            "startOffset": 22949,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 48263,
            "parents": [],
            "secId": "s0110",
            "sentence": "It was the consensus of the Brighton Collaboration Small for Gestational Age Working Group for small for gestational age (SGA) to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about SGA.",
            "startOffset": 47996,
            "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
        },
        {
            "endOffset": 22696,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Congenital infections by Toxoplasma gondii, rubella, cytomegalovirus, herpes simplex virus (HSV), varicella-zoster virus, Treponema, and HIV contribute to 5\u201310% of fetal growth restriction [13,14].",
            "startOffset": 22499,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 44733,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0060",
            "sentence": "Both were developed to improve data comparability.",
            "startOffset": 44683,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 34415,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "When this artifactual identification of preterm infants is taken into account, the reported benefits of customization disappear.",
            "startOffset": 34287,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51752,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0135",
            "sentence": "Past medical history, including hospitalisations, underlying diseases/disorders, pre-immunisation signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications; food allergy; allergic rhinitis; eczema; asthma.",
            "startOffset": 51455,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 60722,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on SGA following immunisation to allow for comparability of data, and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 60466,
            "title": "Data presentation"
        },
        {
            "endOffset": 31797,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is important to select the appropriate comparison charts as the rates of SGA can differ significantly based on the choice of the reference population [66,67].",
            "startOffset": 31636,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 48842,
            "parents": [],
            "secId": "s0110",
            "sentence": "Also, as explained in more detail in the overview paper in this volume, these guidelines have been developed by this working group for guidance only, and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 48592,
            "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
        },
        {
            "endOffset": 27203,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This functional definition aims to identify a population of fetuses at risk for poor pregnancy outcomes, and excludes fetuses that are SGA but are not pathologically small.",
            "startOffset": 27031,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54519,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Results of laboratory examinations, surgical and/or pathological findings and diagnoses if present.",
            "startOffset": 54420,
            "title": "The adverse event"
        },
        {
            "endOffset": 29695,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Among the national population-based weight references used by the investigators, two older US population based standards were mentioned [54,55], as well as population references for Taiwan [56], France [57], Canada [58], The Netherlands [59], and Sweden [53].",
            "startOffset": 29436,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34751,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Additionally important for preterm infants, the birth weight for gestational age reference charts differ from ultrasound-based fetal weight charts.",
            "startOffset": 34604,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41920,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0045",
            "sentence": "The Working Group decided against using \u201ctreatment\u201d or \u201ctreatment response\u201d towards fulfillment of the SGA case definition, as specific SGA treatments are not currently used or accepted.",
            "startOffset": 41734,
            "title": "Influence of treatment on fulfilment of case definition"
        },
        {
            "endOffset": 26701,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Small for gestational age (SGA), is commonly used as a proxy for intrauterine growth restriction (IUGR), particularly in settings where serial ultrasonography is not readily available [2,25].",
            "startOffset": 26510,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 63999,
            "parents": [],
            "secId": "s0200",
            "sentence": "They do not necessarily represent the official positions of each participant\u2019s Organization (e.g., government, university, or corporation).",
            "startOffset": 63860,
            "title": "Disclaimer"
        },
        {
            "endOffset": 51147,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "Case/study participant identifiers (e.g. first name initial followed by last name initial) or code (or in accordance with country-specific data protection laws).",
            "startOffset": 50986,
            "title": "Demographics"
        },
        {
            "endOffset": 26938,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "If SGA babies have been the subject of intrauterine growth retardation (IUGR), the term \u201cSGA associated with IUGR\u201d is used.",
            "startOffset": 26815,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29313,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In two studies, in addition to the 10th percentile cut-off, the investigators used other cut-offs to define very small neonates, like low 3rd and low 5th percentiles [49,50].",
            "startOffset": 29139,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42163,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "The diagnosis of SGA is made at birth after the measurement of birth weight, calculation of gestational age and ascertainment of weight for gestational age percentile when compared to a reference standard.",
            "startOffset": 41958,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 28275,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is important to emphasize that these tools have been developed in the absence of any data supporting such an association but rather to facilitate studies of the safety of vaccines used in pregnancy.",
            "startOffset": 28074,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29436,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In three studies, SGA was defined as a births weight below 2 standard deviations from the national reference mean [51\u201353].",
            "startOffset": 29314,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31189,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Early ultrasound (accuracy \u00b15 days if first trimester and \u00b17 days after first trimester), ideally in the first trimester, is the gold standard for gestational age assessment [62,64].",
            "startOffset": 31007,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26232,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Both hypoxaemia and acidaemia can also be detected clinically by changes in fetal heart rate as well as the biophysical profile.",
            "startOffset": 26104,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42524,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "The timing of the vaccine receipt or the interval from maternal immunisation and the neonatal birth are not elements of the SGA definition.",
            "startOffset": 42385,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 24409,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Tetanus and influenza vaccines were the first vaccines recommended for use during pregnancy.",
            "startOffset": 24317,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35871,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "On the other hand, if the study vaccine somehow adversely affects maternal health or other factors that impact birth weight, then the increased incidence of SGA may indicate a safety signal.",
            "startOffset": 35681,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54149,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Concurrent signs, symptoms, and diseases.",
            "startOffset": 54108,
            "title": "The adverse event"
        },
        {
            "endOffset": 50205,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0115",
            "sentence": "The additional guidelines have been developed as guidance for the collection of additional information to allow for a more comprehensive understanding of SGA following immunisation.",
            "startOffset": 50024,
            "title": "Data collection"
        },
        {
            "endOffset": 61919,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Although immunisation safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 61756,
            "title": "Data presentation"
        },
        {
            "endOffset": 19678,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This classification was originally developed by a 1995 World Health Organization (WHO) expert committee, and the definition is based on a birthweight-for-gestational-age measure compared to a gender-specific reference population [1,2].",
            "startOffset": 19443,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43963,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0055",
            "sentence": "While IUGR refers to reduced growth velocity in the fetus as supported by at least two intrauterine growth assessments, SGA does not reflect fetal growth but size of the infant at birth [60,61,91].",
            "startOffset": 43766,
            "title": "Differentiation from other (similar/associated) disorders"
        },
        {
            "endOffset": 26814,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "However, fetuses that are SGA are not necessarily growth restricted; they in fact may be constitutionally small.",
            "startOffset": 26702,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27489,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A related term is low birth weight (LBW), defined as a birth weight of less than 2500 g, regardless of gestational age at the time of birth.",
            "startOffset": 27349,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40527,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0035",
            "sentence": "The number of symptoms and/or signs that will be documented for each case may vary considerably.",
            "startOffset": 40431,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 42622,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "In fact, the definition is meant to stand alone independent of whether the mother was vaccinated.",
            "startOffset": 42525,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 20150,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "During normal placentation, several changes occur, including differentiation of the endometrium to decidua, development of the fetal placental trophoplast to invade the decidua, migration and differentiation of trophoblast, and remodeling of the uterine arteries [4].",
            "startOffset": 19883,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22149,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Maternal diseases such as anemia and malnutrition may also affect fetal growth.",
            "startOffset": 22070,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22499,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The Brighton Collaboration fetal growth restriction manuscript addresses the impact of obstetric conditions on fetal growth restriction more fully [12].",
            "startOffset": 22347,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32897,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The majority of the charts in the literature are reference charts that differ considerably in terms of sample size, population characteristics, representativeness (hospital based versus population-based), inclusion/exclusion criteria, and methods of gestational age assessment [2,66].",
            "startOffset": 32613,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32436,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A recent standard sex-specific birth weight for gestational age chart using neonatal growth measures from healthy women in eight countries with ultrasound assessed gestational age has been published by the INTERGROWTH-21st Project group [70].",
            "startOffset": 32194,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22346,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "However, classical utero-placental dysfunction accounts for the vast majority of cases of \u201cplacental\u201d FGR, as well as to a variety of conditions such as pre-eclampsia and placental abruption [11].",
            "startOffset": 22150,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 63312,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Whether the day of immunisation was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis;",
            "startOffset": 63225,
            "title": "Data presentation"
        },
        {
            "endOffset": 20495,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Mor and Cardenas categorized pregnancy into three different immunological stages [6].",
            "startOffset": 20410,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 52905,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Route and method of administration (e.g. intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 52754,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 22069,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Genetic and chromosomal disorders, fetal malformation, infection (e.g. rubella or cytomegalovirus), and toxic substances (e.g. alcohol, cocaine, or smoking) can contribute to FGR.",
            "startOffset": 21890,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41281,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0040",
            "sentence": "Our approach is to provide adequate diagnostic specificity without being overly restrictive with the objective of making available a definition that is applicable in high, middle, and low-income countries.",
            "startOffset": 41076,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 62594,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Any publication of data on SGA should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 62460,
            "title": "Data presentation"
        },
        {
            "endOffset": 23316,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In a case-control study of 492 pregnant Malawian women, a significant increase of placental complement C5a levels was associated with an increased risk of delivering a small-for-gestational-age infant [18].",
            "startOffset": 23110,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 50023,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0115",
            "sentence": "These data elements include an identifiable reporter and patient, one or more prior immunisations, and a detailed description of the adverse event, in this case, of SGA following immunisation.",
            "startOffset": 49831,
            "title": "Data collection"
        },
        {
            "endOffset": 21236,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Furthermore, different Pattern Recognition Receptors (PRRs), including Toll-like receptors and Nod-like receptors, and the innate immune system play a vital role in this process.",
            "startOffset": 21058,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26346,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The Brighton Collaboration growth restriction and fetal distress guidelines further explore these issues [12,24].",
            "startOffset": 26233,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 61308,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "All reported events of SGA should be presented according to the categories listed in guideline 31.",
            "startOffset": 61210,
            "title": "Data presentation"
        },
        {
            "endOffset": 56710,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0155",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 56568,
            "title": "Data analysis"
        },
        {
            "endOffset": 27928,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Approximately one third of LBW babies weighing less than 2500 g are also SGA [12,27].",
            "startOffset": 27843,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25263,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The key question that remains is related to the safety and optimum timing of vaccination and if maternal vaccination has any negative effects on the immune system [23].",
            "startOffset": 25095,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27766,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Additional related terms include very low birth weight (VLBW) which refers to less than 1500 g, and extremely low birth weight (ELBW) which is less than 1000 g. Normal weight at term delivery is 2500\u20134200 g. LBW is discussed further in a separate document for this definition.",
            "startOffset": 27490,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25094,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Currently, the World Health Organization (WHO) provides guidance for vaccination during pregnancy (Table 1).",
            "startOffset": 24986,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 63434,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Whether the date of onset5 and/or the date of first observation6 and/or the date of diagnosis7 was used for analysis; and",
            "startOffset": 63313,
            "title": "Data presentation"
        },
        {
            "endOffset": 25854,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The duration of this compensatory phase is variable.",
            "startOffset": 25802,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29138,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In most of these studies, SGA was defined as the lowest 10th percentile of the gestational age-specific birth weight within the cohort of live births, not stratified or stratified by gender [20,22,34\u201348].",
            "startOffset": 28934,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54104,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Date/time of onset,6 first observation7 and diagnosis,8 end of episode9 and final outcome.10",
            "startOffset": 53297,
            "title": "The adverse event"
        },
        {
            "endOffset": 54419,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Method of measurement (e.g. type of thermometer, oral or other route, duration of measurement, etc.);",
            "startOffset": 54318,
            "title": "The adverse event"
        },
        {
            "endOffset": 25445,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Placentally mediated severe FGR, indicated by abnormal uterine and umbilical artery Doppler velocimetry, is associated with impaired transplacental gas transfer and fetal hypoxaemia.",
            "startOffset": 25263,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23686,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Maternal vaccination during pregnancy has emerged as a recommended public health approach to prevent maternal and childhood infections.",
            "startOffset": 23551,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37526,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "(The search strategy used was as follows: (pregnancy OR pregnant) AND (vaccine OR vaccination OR immunisation) AND (pertussis OR Tdap OR tetanus OR influenza); article publication dates between 1 January 2006 and 1 June 2016.)",
            "startOffset": 37300,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for SGA as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 28412,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The outcome of SGA has been examined in several published studies of the safety of influenza and pertussis vaccination during pregnancy.",
            "startOffset": 28276,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39016,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0030",
            "sentence": "The working group considered several other related outcomes in its discussions.",
            "startOffset": 38937,
            "title": "Related terms - small for gestational age"
        },
        {
            "endOffset": 34115,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Arguably, their reported improved ability to identify fetuses at risk of adverse outcome appears to be a consequence of an artifact rather than a real improvement in predictive ability [78,80\u201384].",
            "startOffset": 33919,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42237,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "Once the diagnosis has been made, no further change would be anticipated.",
            "startOffset": 42164,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 61446,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Data on possible SGA events should be presented in accordance with data collection guidelines 1\u201324 and data analysis guidelines 31\u201336.",
            "startOffset": 61312,
            "title": "Data presentation"
        },
        {
            "endOffset": 52371,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 52265,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 24593,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There was no difference in pregnancy outcome measures, including small for date.",
            "startOffset": 24513,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 50837,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0120",
            "sentence": "Relation to the patient (e.g., immuniser [clinician,nurse], family member [indicaterelationship], other).",
            "startOffset": 50732,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 23946,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "All current maternal vaccines were initially designed for and tested in non-pregnant populations, but the diverse immune modulations during pregnancy may cause pregnant women to respond sub-optimally or differently compared with non-pregnant populations [19].",
            "startOffset": 23687,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21889,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Traditionally, the causes for \u201cpathological\u201d growth restriction are subdivided into fetal, placental and maternal.",
            "startOffset": 21775,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 36079,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A standard definition and evaluation of SGA would support the comparability of conclusions related to the benefits and safety concerns attributed to maternal immunisation with a given vaccine across studies.",
            "startOffset": 35872,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 52933,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "Needle length and gauge.",
            "startOffset": 52909,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 63224,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "The instrument of data collection (e.g. standardized questionnaire, diary card, report form);",
            "startOffset": 63131,
            "title": "Data presentation"
        },
        {
            "endOffset": 48591,
            "parents": [],
            "secId": "s0110",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, a post-marketing surveillance or epidemiological study, or an individual report of SGA.",
            "startOffset": 48345,
            "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
        },
        {
            "endOffset": 31878,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There are two types of charts available including reference and standard charts.",
            "startOffset": 31798,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54317,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Values and units of routinely measured parameters (e.g. temperature, blood pressure) \u2013 in particular those indicating the severity of the event;",
            "startOffset": 54173,
            "title": "The adverse event"
        },
        {
            "endOffset": 32051,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Standard charts are prescriptive and delineate how a population should grow under optimal environmental and health conditions and are based on low-risk pregnancies [68,69].",
            "startOffset": 31879,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 50729,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0120",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 50637,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 20738,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is associated with increased levels of interleukin (IL)-8, macrophage chemo-attractor protein 1 (MCP-1), and activated T cells.",
            "startOffset": 20608,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 24801,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In an observational cohort study from UK, Donegan and colleagues examined maternal and neonatal outcomes among 6185 pertussis vaccinated pregnant women and 18,523 healthy unvaccinated historic controls [21].",
            "startOffset": 24594,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35582,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This need is especially apparent in studies of maternal immunisation where SGA may be a critical endpoint, either as a positive outcome related to vaccination or as related to safety.",
            "startOffset": 35399,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43510,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "In some settings it may be impossible to obtain a clear timeline of the event, particularly in less developed or rural settings.",
            "startOffset": 43382,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 22948,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Several investigators believe that congenital infection could be associated with a spectrum of disease, and it could be quite variable, ranging from severe clinical manifestations to mild disease only presenting with a small for gestational age fetus.",
            "startOffset": 22697,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 48344,
            "parents": [],
            "secId": "s0110",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 48264,
            "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
        },
        {
            "endOffset": 24069,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In addition, vaccine efficacy could be affected by other factors including the dose, route, and timing of the vaccination.",
            "startOffset": 23947,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 52063,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0135",
            "sentence": "(e.g. immunoglobulins, blood transfusion and immunosuppressants).",
            "startOffset": 51998,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 19882,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Several mechanisms work together to protect the fetus from rejection [3].",
            "startOffset": 19809,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 20607,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The first pro-inflammatory phase, occurring during the first trimester, includes implantation and placentation.",
            "startOffset": 20496,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37299,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "To guide the decision-making for the case definition and guidelines, a literature search in PubMed was performed and identified over twenty vaccine studies in which SGA was mentioned and defined.",
            "startOffset": 37104,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for SGA as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 20945,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is characterized by predominant anti-inflammatory cytokines (IL-4, IL10 and IL-13).",
            "startOffset": 20859,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35080,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "As such, the birth weight for gestational charts underestimate the prevalence of IUGR [89].",
            "startOffset": 34989,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 63693,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Use of this case definition for SGA, in the abstract or methods section of a publication.15",
            "startOffset": 63435,
            "title": "Data presentation"
        },
        {
            "endOffset": 28585,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In one randomised clinical trial of influenza immunisation in pregnant women in Bangladesh, SGA was defined as less than 10th percentile weight for gestational age [28,29].",
            "startOffset": 28413,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 49413,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                }
            ],
            "secId": "s0115",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition, which are not repeated in these guidelines.",
            "startOffset": 49221,
            "title": "Data collection"
        },
        {
            "endOffset": 63040,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "The characteristics of the surveillance system (e.g. population served, mode of report solicitation);",
            "startOffset": 62939,
            "title": "Data presentation"
        },
        {
            "endOffset": 63859,
            "parents": [],
            "secId": "s0200",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 63703,
            "title": "Disclaimer"
        },
        {
            "endOffset": 43765,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0055",
            "sentence": "As described above, other similar disorders to SGA include IUGR.",
            "startOffset": 43701,
            "title": "Differentiation from other (similar/associated) disorders"
        },
        {
            "endOffset": 30005,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The WHO definition of SGA, outlined by a 1995 WHO expert committee, remains the most widely utilized definition of SGA [1,2].",
            "startOffset": 29880,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51306,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                },
                {
                    "id": "s0125",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0130",
            "sentence": "For infants: Gestational age and birth weight.",
            "startOffset": 51260,
            "title": "Demographics"
        },
        {
            "endOffset": 64158,
            "parents": [],
            "secId": "s0200",
            "sentence": "Specifically, the findings and conclusions in this paper are those of the authors and do not necessarily represent the views of their respective institutions.",
            "startOffset": 64000,
            "title": "Disclaimer"
        },
        {
            "endOffset": 43381,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "Further, SGA often occurs outside the controlled setting of a clinical trial or hospital.",
            "startOffset": 43292,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 44682,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0060",
            "sentence": "Neither case definition nor guidelines are intended to guide or establish criteria for management of ill infants, children, or adults.",
            "startOffset": 44548,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 52750,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0140",
            "sentence": "The anatomical sites (including left or right side) of all immunisations (e.g. vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 52602,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 40638,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0035",
            "sentence": "The case definition has been formulated such that the Level 1 definition is highly specific for the condition.",
            "startOffset": 40528,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 28795,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In this trial, two reference standards were used - the reference values for distributions of birth weights from the United States [30] and the global reference standard from the World Health Organization [31].",
            "startOffset": 28586,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33037,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A recent meta-analysis identified 26 commonly cited reference charts which include the 10th percentile cut point to define SGA status [66].",
            "startOffset": 32898,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 62390,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 62265,
            "title": "Data presentation"
        },
        {
            "endOffset": 24317,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In spite of the success of several maternal vaccines, many gaps exist in our knowledge of this promising public health strategy and impact on fetal growth during pregnancy.",
            "startOffset": 24145,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30150,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This classifies SGA infants as having a birth weight for gestational age below the 10th percentile based on a sex-specific reference population.",
            "startOffset": 30006,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31635,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A main challenge in defining SGA is selecting the appropriate comparison population [2,60,66].",
            "startOffset": 31541,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 61756,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 61650,
            "title": "Data presentation"
        },
        {
            "endOffset": 24985,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There were no significant differences between the two groups regarding low birth weight or other maternal and neonatal outcomes [21], and these findings were confirmed by others [22].",
            "startOffset": 24802,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 61206,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomised controlled trials, systematic reviews, and meta-analyses of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of Improving the quality of reports of meta-analyses of randomised controlled trials (QUORUM), and of meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively) [94\u201396].",
            "startOffset": 60723,
            "title": "Data presentation"
        },
        {
            "endOffset": 63130,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "Comparison group(s), if used for analysis;",
            "startOffset": 63088,
            "title": "Data presentation"
        },
        {
            "endOffset": 36834,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Following the process described in the overview paper [90], as well as on the Brighton Collaboration Website, http://www.brightoncollaboration.org/internet/en/index/process.html, the Brighton Collaboration Small for Gestational Age Working Group was formed in 2016 and included members of clinical, academic, public health, and industry backgrounds.",
            "startOffset": 36485,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for SGA as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40918,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0035",
            "sentence": "As maximum specificity normally implies a loss of sensitivity, two additional diagnostic levels have been included in the definition, offering a stepwise increase of sensitivity from Level One down to Level Three, while retaining an acceptable level of specificity at all levels.",
            "startOffset": 40639,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 53293,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Clinical description of signs and symptoms of SGA, and if there was medical confirmation of the event (i.e. patient seen by physician).",
            "startOffset": 53158,
            "title": "The adverse event"
        },
        {
            "endOffset": 62622,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "It is essential to specify:",
            "startOffset": 62595,
            "title": "Data presentation"
        },
        {
            "endOffset": 41430,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0040",
            "sentence": "Laboratory and pathology findings are not included in the case definition as these examinations are not required to meet the case definition of SGA.",
            "startOffset": 41282,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 27842,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It is important to be clear that SGA is not a synonym of LBW, VLBW or ELBW.",
            "startOffset": 27767,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 44278,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0055",
            "sentence": "An infant who is SGA however, does not imply that the infant has suffered from IUGR, and infants who experience a short duration of IUGR will not necessarily be SGA at birth [60,61,91].",
            "startOffset": 44093,
            "title": "Differentiation from other (similar/associated) disorders"
        },
        {
            "endOffset": 45310,
            "parents": [],
            "secId": "s0070",
            "sentence": "SGA (small for gestational age) definition: weight below 10th percentile for gestational age as assessed against a validated global, regional or local standard.",
            "startOffset": 45150,
            "title": "Case definition of small for gestational age3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
        },
        {
            "endOffset": 25613,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This triggers compensatory re-distribution of blood towards essential organs (brain, heart, and adrenals) and decreases blood flow to other organs (kidneys and bowel).",
            "startOffset": 25446,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33819,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "However, although maternal height, weight and ethnicity are significant predictors of fetal size, they do not explain a large proportion of the birth weight variability [78,79], and therefore, their utility for customization is limited.",
            "startOffset": 33583,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54547,
            "parents": [
                {
                    "id": "s0110",
                    "title": "Guidelines for data collection, analysis and presentation of small for gestational age"
                },
                {
                    "id": "s0115",
                    "title": "Data collection"
                }
            ],
            "secId": "s0145",
            "sentence": "Treatment given for SGA.",
            "startOffset": 54523,
            "title": "The adverse event"
        },
        {
            "endOffset": 62938,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "The type of surveillance (e.g. passive or active surveillance);",
            "startOffset": 62875,
            "title": "Data presentation"
        },
        {
            "endOffset": 38891,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0025",
            "sentence": "They instead reflect diagnostic certainty (see below).",
            "startOffset": 38837,
            "title": "The term small for gestational age"
        },
        {
            "endOffset": 42794,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0050",
            "sentence": "A definition designed to be a suitable tool for describing relationships requires ascertainment of the outcome (e.g. SGA) independent from the exposure (e.g. vaccination).",
            "startOffset": 42623,
            "title": "Timing post maternal immunisation"
        },
        {
            "endOffset": 40431,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0035",
            "sentence": "Detailed information about the severity of the event should additionally always be recorded, as specified by the data collection guidelines.",
            "startOffset": 40291,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 44954,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0065",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e. every three to five years) or more often if needed.",
            "startOffset": 44751,
            "title": "Periodic review"
        },
        {
            "endOffset": 21527,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The complement system can affect angiogenesis-related endothelial cell function.",
            "startOffset": 21447,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 23551,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "C5a was significantly increased in placental malaria and was negatively correlated with the angiogenic factor angiopoietin-1 and positively correlated with angiopoietin-2, soluble endoglin, and vascular endothelial growth factor [18].",
            "startOffset": 23317,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 63087,
            "parents": [
                {
                    "id": "s0190",
                    "title": "Total"
                }
            ],
            "secId": "s0195",
            "sentence": "The search strategy in surveillance databases;",
            "startOffset": 63041,
            "title": "Data presentation"
        },
        {
            "endOffset": 36309,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Herein, to facilitate data interpretation and promote scientific understanding of the same, we propose the tools necessary for determination of SGA in the setting of clinical trials as well as post-licensure surveillance systems.",
            "startOffset": 36080,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for small for gestational age (SGA) as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40990,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of SGA as an adverse event following maternal immunisation"
                }
            ],
            "secId": "s0035",
            "sentence": "In this way it is hoped that all possible cases of SGA can be captured.",
            "startOffset": 40919,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        }
    ],
    "docId": "S0264410X17301019",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "contact@brightoncollaboration.org",
                "first": "Elizabeth P.",
                "initial": "E.P.",
                "last": "Schlaudecker"
            },
            {
                "email": null,
                "first": "Flor M.",
                "initial": "F.M.",
                "last": "Munoz"
            },
            {
                "email": null,
                "first": "Azucena",
                "initial": "A.",
                "last": "Bardaj\u00ed"
            },
            {
                "email": null,
                "first": "Nansi S.",
                "initial": "N.S.",
                "last": "Boghossian"
            },
            {
                "email": null,
                "first": "Asma",
                "initial": "A.",
                "last": "Khalil"
            },
            {
                "email": null,
                "first": "Hatem",
                "initial": "H.",
                "last": "Mousa"
            },
            {
                "email": null,
                "first": "Mirjana",
                "initial": "M.",
                "last": "Nesin"
            },
            {
                "email": null,
                "first": "Muhammad Imran",
                "initial": "M.I.",
                "last": "Nisar"
            },
            {
                "email": null,
                "first": "Vitali",
                "initial": "V.",
                "last": "Pool"
            },
            {
                "email": null,
                "first": "Hans M.L.",
                "initial": "H.M.L.",
                "last": "Spiegel"
            },
            {
                "email": null,
                "first": "Milagritos D.",
                "initial": "M.D.",
                "last": "Tapia"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": null,
                "first": "Steven",
                "initial": "S.",
                "last": "Black"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2017.01.040",
        "firstpage": "6518",
        "issn": "0264410X",
        "keywords": [
            "Adverse event",
            "Brighton collaboration",
            "Case definition",
            "GAIA",
            "Guidelines",
            "Maternal immunisation",
            "Small for gestational age"
        ],
        "lastpage": "6528",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data"
    }
}